Nrf2 as a potential target for Parkinson's disease therapy
Yingcai Niu1, Jing Zhang2, Miaoxian Dong3
1The Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China.
Journal of Molecular Medicine (Berlin, Germany)
|April 12, 2021
Summary
Targeting nuclear factor erythroid 2-related factor 2 (Nrf2) may offer a new therapeutic strategy for Parkinson's disease (PD). Activating Nrf2 can help mitigate oxidative stress, a key factor in PD progression and dopaminergic neuron loss.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Parkinson's disease (PD) involves motor and nonmotor symptoms due to dopaminergic neuron loss.
- Current treatments offer symptomatic relief but lack disease-modifying capabilities.
- Oxidative stress is a critical factor in PD initiation and progression.
Purpose of the Study:
- To review the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in Parkinson's disease.
- To explore Nrf2 regulation via Keap1-dependent and independent pathways.
- To discuss Nrf2 activators as potential therapeutic agents for PD.
Main Methods:
- Literature review of studies on Nrf2, oxidative stress, and Parkinson's disease.
- Analysis of mechanisms regulating Nrf2 activity (e.g., protein kinase C, MAPKs, PI3K).
- Examination of Keap1-dependent and Keap1-independent Nrf2 activation pathways.
Main Results:
- Nrf2 is crucial for maintaining redox homeostasis via the antioxidant response element.
- Specific signaling pathways regulate Nrf2 activity in the context of PD.
- Small molecule activators of Nrf2 are being investigated for PD treatment.
Conclusions:
- Targeting Nrf2 presents a promising therapeutic avenue for mitigating oxidative stress in PD.
- Understanding Nrf2 regulation is key to developing effective disease-modifying therapies for Parkinson's disease.
- Nrf2 activators, including specific compounds, show potential for treating PD.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
23.8K
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
17.1K
Related Concept Videos
01:24Parkinson's Disease: Treatment
694
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
694
01:15Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
01:37Neural Regulation
41.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.1K
02:26NF-κB-dependent Signaling Pathway
8.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.3K
01:31Transducer Mechanism: Nuclear Receptors
2.0K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.0K